Next Article in Journal
A Novel TLR4-SYK Interaction Axis Plays an Essential Role in the Innate Immunity Response in Bovine Mammary Epithelial Cells
Next Article in Special Issue
Modulating Morphological and Redox/Glycative Alterations in the PCOS Uterus: Effects of Carnitines in PCOS Mice
Previous Article in Journal
COVID-19 Related Myocarditis and Myositis in a Patient with Undiagnosed Antisynthetase Syndrome
 
 
Article
Peer-Review Record

Hyperandrogenic Symptoms Are a Persistent Suffering in Midlife Women with PCOS; a Prospective Cohort Study in Sweden

Biomedicines 2023, 11(1), 96; https://doi.org/10.3390/biomedicines11010096
by Sofia Persson 1,*, Kumari A. Ubhayasekera 2, Jonas Bergquist 2, Sahruh Turkmen 3, Inger Sundström Poromaa 1 and Evangelia Elenis 1,4
Reviewer 1:
Biomedicines 2023, 11(1), 96; https://doi.org/10.3390/biomedicines11010096
Submission received: 22 November 2022 / Revised: 15 December 2022 / Accepted: 20 December 2022 / Published: 30 December 2022
(This article belongs to the Special Issue Molecular Research on Polycystic Ovary Syndrome (PCOS) 2.0)

Round 1

Reviewer 1 Report

Thanks for the interesting study about PCO patients

I recommend publication

 

Additional pitfalls of control definition: “Controls were matched for age and area of residence and were randomly selected from the population”

Comments for author File: Comments.docx

Author Response

The authors thanks for the review and the recommendation for publication. We have now revised the manuscript and clarified how the controls were selected.

Reviewer 2 Report

The authors present the results of a multicenter prospective cohort study dedicated to age dynamics of hyperandrogenic symptoms in patients with PCOS and related quality of life.  The topic is of importance and the presented data increase the body of evidence regarding the persistence of hyperandrogenism in the midlife period associated with a decrease in quality of life.

The manuscript was reviewed using the STROBE Statement—Checklist of items that should be included in reports of cohort studies (https://www.equator-network.org/reporting-guidelines/strobe/).

The abstract provides an informative and balanced summary of what was done and what was found; the Introduction presents the scientific background and states objectives. The Methods section clearly describes the key elements of study design, settings, and study population. Importantly, the authors used only validated methods for hormone analysis as well as for quality-of-life assessment.

The comments and suggestions by sections:

Consider adding a flow diagram and race characteristics of study participants (if you included not only Caucasians, but also Asians etc.).

Indicate the number of participants with missing data for each variable of interest and describe how you treat missing data in the Statistical analysis section.

Please also consider mentioning the absence of data on DHEAS as a study limitation in the discussion section

There are some grammatical errors and typos in the manuscript.

The reviewer’s decision: Accept after minor revision (corrections to minor methodological errors and text editing)

Author Response

The authors thanks for the reviw and have revised the manuscript in line with the comments.

We considered to add a flow diagram over the study population, but we prefer to keep the information in Table 1, which was updated with country of birth. The majority of study participant originated from Sweden or other Nordic countries.

The information on missing data has now been described in the method section and is also discussed in the discussion section.

A section on the absence of DHEAS has been added to the study limitations.

The manuscript has been revised and edited for linguistic errors.

Back to TopTop